Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis

par Paula Rackoff
Publié 2009

Comparison of OSTA, FRAX and BMI for Predicting Postmenopausal Osteoporosis in a Han Population in Beijing: A Cross Sectional Study

par Fan Z, Li X, Zhang X, Yang Y, Fei Q, Guo A
Publié 2020

The predictive role of monocyte-lymphocyte ratio and plateletlymphocyte ratio in postmenopausal osteoporosis

par Ibrahim Kale
Publié 2021

The interrelationship of bone and cardiovascular remodeling biomarkers and clinical peculiarities of coronary artery disease in postmenopausal women

par Natalia Serhiivna Mykhailovska, Iryna Olehivna Stetsiuk, Tamila Olehivna Kulynych, Svitlana Vasylivna Gorbachova, Igor Valentynovych Zhulkevych
Publié 2020

Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis

par Liu Z, Liang W, Kang D, Chen Q, Ouyang Z, Yan H, Huang B, Jin D, Chen Y, Li Q
Publié 2020

LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α

par Yu H, Zhou W, Yan W, Xu Z, Xie Y, Zhang P
Publié 2019

Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene

par Luigi Gennari, Daniela Merlotti, Ranuccio Nuti
Publié 2010

Teriparatide in East Asian Postmenopausal Women with Osteoporosis in a Real-World Setting: A Baseline Analysis of the Asia and Latin America Fracture Observational Study (ALAFOS)

par Chen CH, Lim SJ, Oh JK, Huang TW, Zeng YH, Wu MT, Yang HL, Cheung JPY, Kim JW, Han JH, Huo L, Lin TJ, Zhou G, Wu WS
Publié 2020

Teriparatide in East Asian Postmenopausal Women with Osteoporosis in a Real-World Setting: A Baseline Analysis of the Asia and Latin America Fracture Observational Study (ALAFOS) [...

par Chen CH, Lim SJ, Oh JK, Huang TW, Zeng YH, Wu MT, Yang HL, Cheung JPY, Kim JW, Han JH, Huo L, Lin TJ, Zhou G, Wu WS
Publié 2020

Anabolic Bone Stimulus Requires a Pre-Exercise Meal and 45-Minute Walking Impulse of Suprathreshold Speed-Enhanced Momentum to Prevent or Mitigate Postmenopausal Osteoporosis withi...

par Qingyun Zheng, Thomas Kernozek, Adam Daoud-Gray, Katarina T. Borer
Publié 2021

Discontinuation of PTH therapy amplifies bone loss by increasing oxidative stress: An event ameliorated by sequential IL-17 neutralizing antibody therapy

par Krishna Bhan Singh, Reena Rai, Sonu Khanka, Divya Singh
Publié 2022

Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model

par Hongxia Zhao, Xiaoqun Li, Dianying Zhang, Haiyan Chen, Yufan Chao, Kaiwen Wu, Xin Dong, Jiacan Su
Publié 2018

Regulatory SNP of RREB1 is Associated With Bone Mineral Density in Chinese Postmenopausal Osteoporosis Patients

par Shuo Feng, Han Wang, Yumeng Yan, Xin Su, Jintao Ao, Wei Chen
Publié 2021

MicroRNA-151a-3p Functions in the Regulation of Osteoclast Differentiation: Significance to Postmenopausal Osteoporosis

par He Y, Chen D, Guo Q, Shi P, You C, Feng Y
Publié 2021